| 000 | 01890 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517211714.0 | ||
| 264 | 0 | _c20190805 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1875-5992 | ||
| 024 | 7 |
_a10.2174/1871520618666180412120128 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPereira, Michelle X G | |
| 245 | 0 | 0 |
_aAntitumor Effect of Pomolic Acid in Acute Myeloid Leukemia Cells Involves Cell Death, Decreased Cell Growth and Topoisomerases Inhibition. _h[electronic resource] |
| 260 |
_bAnti-cancer agents in medicinal chemistry _c2018 |
||
| 300 |
_a1457-1468 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemical synthesis |
| 650 | 0 | 4 |
_aCell Death _xdrug effects |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDNA Cleavage |
| 650 | 0 | 4 |
_aDNA Topoisomerases _xmetabolism |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Screening Assays, Antitumor |
| 650 | 0 | 4 | _aHL-60 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukemia, Myeloid, Acute _xdrug therapy |
| 650 | 0 | 4 | _aModels, Molecular |
| 650 | 0 | 4 | _aMolecular Conformation |
| 650 | 0 | 4 |
_aOleanolic Acid _xanalogs & derivatives |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTopoisomerase Inhibitors _xchemical synthesis |
| 650 | 0 | 4 | _aU937 Cells |
| 700 | 1 | _aHammes, Amanda S O | |
| 700 | 1 | _aVasconcelos, Flavia C | |
| 700 | 1 | _aPozzo, Aline R | |
| 700 | 1 | _aPereira, Thaís H | |
| 700 | 1 | _aCaffarena, Ernesto R | |
| 700 | 1 | _aGattass, Cerli R | |
| 700 | 1 | _aMaia, Raquel C | |
| 773 | 0 |
_tAnti-cancer agents in medicinal chemistry _gvol. 18 _gno. 10 _gp. 1457-1468 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1871520618666180412120128 _zAvailable from publisher's website |
| 999 |
_c28284004 _d28284004 |
||